Resumen:
Introduction – Metabolic Syndrome (MS) is a complex disorder with a strong genetic basis
and a multifactorial etiology. Among the main causes is insulin resistance (IR), which is
widely associated with hyperglycemia. To treat this dysfunction, the Brazilian
Cardioprotective Diet (BCD), a recent therapeutic proposal, stands out. Aim: to see if the
BR-CAD influences hyperglycemia in patients with MS. Goal – Evaluate if diet interventions
with the Brazilian Cardioprotective Diet reduces hyperglycemia in patients with metabolic
syndrome. Materials and methods – Non-randomized, self-controlled clinical trial. The
volunteers were diagnosed with MS, according to the International Diabetes Federation
parameters, and followed the DICA-BR for two months. Glycemic profile (fasting glucose,
fasting insulin, glycated hemoglobin), MetS cofactors (HDL-cholesterol, triglycerides, waist
circumference and blood pressure), anthropometric profile (body weight, body mass index
(BMI), fat and lean mass, arm, abdomen and hip circumferences) were assessed. This research
was approved by the research ethics committee of the State University of Bahia, number:
6.255.205 and was registered with REBEC:RBR-9v9r6vj. Results – There was no significant
difference in the reduction of hyperglycemia (p=0.292); however, there were significant
results for glycated hemoglobin (p=0.001) and HOMA-IR (p=0.018); abdomen circumference
(p=0.001), hip circumference (p=0.004), body weight (p=0.019) and BC (p=0.008).
Conclusions – TIP-BR for two months was not effective in reducing hyperglycemia in
volunteers wit
